Cargando…
High-sensitive cardiac troponin T as a predictor of efficacy and safety after pulmonary vein isolation using focal radiofrequency, multielectrode radiofrequency and cryoballoon ablation catheter
INTRODUCTION: Myocardial injury markers such as high-sensitive cardiac troponin T (hs-cTnT) and creatine kinase MB (CK-MB) reflects the amount of myocardial injury with ablation. The aim of the study was to identify the value of myocardial injury markers to predict outcomes after pulmonary vein isol...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519429/ https://www.ncbi.nlm.nih.gov/pubmed/31168374 http://dx.doi.org/10.1136/openhrt-2018-000949 |
_version_ | 1783418640049111040 |
---|---|
author | Zeljkovic, Ivan Knecht, Sven Pavlovic, Nikola Celikyrut, Umut Spies, Florian Burri, Sarah Mannhart, Dominik Peterhans, Loris Reichlin, Tobias Schaer, Beat Osswald, Stefan Sticherling, Christian Kuhne, Michael |
author_facet | Zeljkovic, Ivan Knecht, Sven Pavlovic, Nikola Celikyrut, Umut Spies, Florian Burri, Sarah Mannhart, Dominik Peterhans, Loris Reichlin, Tobias Schaer, Beat Osswald, Stefan Sticherling, Christian Kuhne, Michael |
author_sort | Zeljkovic, Ivan |
collection | PubMed |
description | INTRODUCTION: Myocardial injury markers such as high-sensitive cardiac troponin T (hs-cTnT) and creatine kinase MB (CK-MB) reflects the amount of myocardial injury with ablation. The aim of the study was to identify the value of myocardial injury markers to predict outcomes after pulmonary vein isolation (PVI) using three different ablation technologies. METHODS: Consecutive patients undergoing PVI using a standard 3.5 mm irrigated-tip radiofrequency catheter (RF-group), an irrigated multielectrode radiofrequency catheter (IMEA-group) and a second-generation cryoballoon (CB-group) were analysed. Blood samples to measure injury markers were taken before and 18–24 hours after the ablation. Procedural complications were collected and standardised follow-up was performed. Logistic regression was used to identify predictors of recurrence and complications. RESULTS: 96 patients (RF group: n=40, IMEA-group: n=17, CB-group: n=39) undergoing PVI only were analysed (82% male, age 59±10 years). After a follow-up of 12 months, atrial fibrillation (AF) recurred in 45% in the RF-group, 29% in the IMEA-group and 36% in the CB-group (p=0.492). Symptomatic pericarditis was observed in 20% of patients in the RF-group, 15% in the IMEA-group and 5% in the CB-group (p=0.131). None of the injury markers was predictive of AF recurrence or PV reconnection after a single procedure. However, hs-cTnT was identified as a predictor of symptomatic pericarditis (OR: 1.003 [1.001 to 1.005], p=0.015). CONCLUSION: Hs-cTnT and CK-MB were significantly elevated after PVI, irrespective of the ablation technology used. None of the myocardial injury markers were predictive for AF recurrence or PV reconnection, but hs-cTnT release predicts the occurrence of symptomatic pericarditis after PVI. |
format | Online Article Text |
id | pubmed-6519429 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-65194292019-06-05 High-sensitive cardiac troponin T as a predictor of efficacy and safety after pulmonary vein isolation using focal radiofrequency, multielectrode radiofrequency and cryoballoon ablation catheter Zeljkovic, Ivan Knecht, Sven Pavlovic, Nikola Celikyrut, Umut Spies, Florian Burri, Sarah Mannhart, Dominik Peterhans, Loris Reichlin, Tobias Schaer, Beat Osswald, Stefan Sticherling, Christian Kuhne, Michael Open Heart Arrhythmias and Sudden Death INTRODUCTION: Myocardial injury markers such as high-sensitive cardiac troponin T (hs-cTnT) and creatine kinase MB (CK-MB) reflects the amount of myocardial injury with ablation. The aim of the study was to identify the value of myocardial injury markers to predict outcomes after pulmonary vein isolation (PVI) using three different ablation technologies. METHODS: Consecutive patients undergoing PVI using a standard 3.5 mm irrigated-tip radiofrequency catheter (RF-group), an irrigated multielectrode radiofrequency catheter (IMEA-group) and a second-generation cryoballoon (CB-group) were analysed. Blood samples to measure injury markers were taken before and 18–24 hours after the ablation. Procedural complications were collected and standardised follow-up was performed. Logistic regression was used to identify predictors of recurrence and complications. RESULTS: 96 patients (RF group: n=40, IMEA-group: n=17, CB-group: n=39) undergoing PVI only were analysed (82% male, age 59±10 years). After a follow-up of 12 months, atrial fibrillation (AF) recurred in 45% in the RF-group, 29% in the IMEA-group and 36% in the CB-group (p=0.492). Symptomatic pericarditis was observed in 20% of patients in the RF-group, 15% in the IMEA-group and 5% in the CB-group (p=0.131). None of the injury markers was predictive of AF recurrence or PV reconnection after a single procedure. However, hs-cTnT was identified as a predictor of symptomatic pericarditis (OR: 1.003 [1.001 to 1.005], p=0.015). CONCLUSION: Hs-cTnT and CK-MB were significantly elevated after PVI, irrespective of the ablation technology used. None of the myocardial injury markers were predictive for AF recurrence or PV reconnection, but hs-cTnT release predicts the occurrence of symptomatic pericarditis after PVI. BMJ Publishing Group 2019-04-20 /pmc/articles/PMC6519429/ /pubmed/31168374 http://dx.doi.org/10.1136/openhrt-2018-000949 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Arrhythmias and Sudden Death Zeljkovic, Ivan Knecht, Sven Pavlovic, Nikola Celikyrut, Umut Spies, Florian Burri, Sarah Mannhart, Dominik Peterhans, Loris Reichlin, Tobias Schaer, Beat Osswald, Stefan Sticherling, Christian Kuhne, Michael High-sensitive cardiac troponin T as a predictor of efficacy and safety after pulmonary vein isolation using focal radiofrequency, multielectrode radiofrequency and cryoballoon ablation catheter |
title | High-sensitive cardiac troponin T as a predictor of efficacy and safety after pulmonary vein isolation using focal radiofrequency, multielectrode radiofrequency and cryoballoon ablation catheter |
title_full | High-sensitive cardiac troponin T as a predictor of efficacy and safety after pulmonary vein isolation using focal radiofrequency, multielectrode radiofrequency and cryoballoon ablation catheter |
title_fullStr | High-sensitive cardiac troponin T as a predictor of efficacy and safety after pulmonary vein isolation using focal radiofrequency, multielectrode radiofrequency and cryoballoon ablation catheter |
title_full_unstemmed | High-sensitive cardiac troponin T as a predictor of efficacy and safety after pulmonary vein isolation using focal radiofrequency, multielectrode radiofrequency and cryoballoon ablation catheter |
title_short | High-sensitive cardiac troponin T as a predictor of efficacy and safety after pulmonary vein isolation using focal radiofrequency, multielectrode radiofrequency and cryoballoon ablation catheter |
title_sort | high-sensitive cardiac troponin t as a predictor of efficacy and safety after pulmonary vein isolation using focal radiofrequency, multielectrode radiofrequency and cryoballoon ablation catheter |
topic | Arrhythmias and Sudden Death |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519429/ https://www.ncbi.nlm.nih.gov/pubmed/31168374 http://dx.doi.org/10.1136/openhrt-2018-000949 |
work_keys_str_mv | AT zeljkovicivan highsensitivecardiactroponintasapredictorofefficacyandsafetyafterpulmonaryveinisolationusingfocalradiofrequencymultielectroderadiofrequencyandcryoballoonablationcatheter AT knechtsven highsensitivecardiactroponintasapredictorofefficacyandsafetyafterpulmonaryveinisolationusingfocalradiofrequencymultielectroderadiofrequencyandcryoballoonablationcatheter AT pavlovicnikola highsensitivecardiactroponintasapredictorofefficacyandsafetyafterpulmonaryveinisolationusingfocalradiofrequencymultielectroderadiofrequencyandcryoballoonablationcatheter AT celikyrutumut highsensitivecardiactroponintasapredictorofefficacyandsafetyafterpulmonaryveinisolationusingfocalradiofrequencymultielectroderadiofrequencyandcryoballoonablationcatheter AT spiesflorian highsensitivecardiactroponintasapredictorofefficacyandsafetyafterpulmonaryveinisolationusingfocalradiofrequencymultielectroderadiofrequencyandcryoballoonablationcatheter AT burrisarah highsensitivecardiactroponintasapredictorofefficacyandsafetyafterpulmonaryveinisolationusingfocalradiofrequencymultielectroderadiofrequencyandcryoballoonablationcatheter AT mannhartdominik highsensitivecardiactroponintasapredictorofefficacyandsafetyafterpulmonaryveinisolationusingfocalradiofrequencymultielectroderadiofrequencyandcryoballoonablationcatheter AT peterhansloris highsensitivecardiactroponintasapredictorofefficacyandsafetyafterpulmonaryveinisolationusingfocalradiofrequencymultielectroderadiofrequencyandcryoballoonablationcatheter AT reichlintobias highsensitivecardiactroponintasapredictorofefficacyandsafetyafterpulmonaryveinisolationusingfocalradiofrequencymultielectroderadiofrequencyandcryoballoonablationcatheter AT schaerbeat highsensitivecardiactroponintasapredictorofefficacyandsafetyafterpulmonaryveinisolationusingfocalradiofrequencymultielectroderadiofrequencyandcryoballoonablationcatheter AT osswaldstefan highsensitivecardiactroponintasapredictorofefficacyandsafetyafterpulmonaryveinisolationusingfocalradiofrequencymultielectroderadiofrequencyandcryoballoonablationcatheter AT sticherlingchristian highsensitivecardiactroponintasapredictorofefficacyandsafetyafterpulmonaryveinisolationusingfocalradiofrequencymultielectroderadiofrequencyandcryoballoonablationcatheter AT kuhnemichael highsensitivecardiactroponintasapredictorofefficacyandsafetyafterpulmonaryveinisolationusingfocalradiofrequencymultielectroderadiofrequencyandcryoballoonablationcatheter |